Main Article Content

Authors

Abstract

Objective: To assess the self-reported vaccination in older adults within the city of Bogotá and its distribution by sociodemographic factors.

Methods: Data analyzed was taken from the SABE-Bogotá study. A total of 2000 persons aged 60 years and older were selected for this cross-sectional population-based study. Bivariate and multivariate analyses were performed testing the association between vaccination and sociodemographic factors.

Results: A total of 73.0% of respondents received the influenza vaccine, 57.8% received pneumococcal vaccine and 47.6% received tetanus vaccine. In multivariate analyses, individuals aged between 65-74 years had higher odds of receiving influenza, pneumococcus and tetanus vaccination, compared to those between 60-64 years. Older adults with higher socioeconomic status (SES) had lower odds of having influenza and pneumococcus vaccines, compared to those with lower SES (OR= 0.16 95% confidence intervals= CI 0.08-0.30; OR 0.20 95% CI 0.10-0.38, respectively).  Individuals covered by health insurance (contributive or subsidized) had higher odds (between 3 and 5 times higher) of having influenza, pneumococcus and tetanus vaccination, compared to those with no insurance.

Conclusion: Older adults between 65 and 74 years, those with health care coverage and people with low SES are groups that have increased odds for self-reported vaccination. Further studies should identify factors that increase vaccination coverage in these groups and implement interventions targeted at improving coverage among older adults in general.

Carlos Cano, Instituto de envejecimiento, Pontificia Universidad Javeriana. Unidad de Geriatria, Departamento de Medicina Interna, Hospital Universitario San Ignacio.

Bogotá, Cundinamarca

Carlos Reyes-Ortiz, 2. University of Texas Medical School, Department of Internal Medicine, Division of Geriatric and Palliative Medicine, Houston, TX, USA.

UTHealth, The University of Texas Health Science Center at Houston, Department of Internal Medicine, Division of Geriatric and Palliative Medicine, Houston, TX, USA.

Miguel Germán Borda, 1. Instituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá Colombia. 2. Semillero de Neurociencias y Envejecimiento, Facultad de Medicina, Pontificia Universiadad Javeriana.

Instituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá Colombia.Semillero de Neurociencias y Envejecimiento, Facultad de Medicina, Pontificia Universiadad Javeriana, Bogotá Colombia.

Antonio Arciniegas, Instituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá Colombia. 2. Semillero de Neurociencias y Envejecimiento, Facultad de Medicina, Pontificia Universiadad Javeriana.

Instituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá Colombia.Semillero de Neurociencias y Envejecimiento, Facultad de Medicina, Pontificia Universiadad Javeriana, Bogotá Colombia.
Cano, C., Reyes-Ortiz, C., Borda, M. G., & Arciniegas, A. (2024). Self-reported vaccination in the elderly: SABE study Bogotá, Colombia. Colombia Medica, 47(1), 25–30. https://doi.org/10.25100/cm.v47i1.2107 (Original work published March 30, 2016)

Canning D. The causes and consequences of demographic transition. Population studies. Nov 2011;65(3):353-361.

Lee R. The Demographic Transition: Three Centuries of Fundamental Change. Journal of Economic Perspectives. Fal 2003;17(4):167-190.

Burns E, Goodwin J. Immunodeficiency of Aging. Drugs & Aging. 1997/11/01 1997;11(5):374-397.

Cano C. Programas de Vacunación en el Adulto Mayor. Prevención en Geriatría - II Curso de la Academía Latinoamericana de Medicina del Adulto Mayor, ALMA.: CIEDESS; 2011.

CDC. Recommended adult immunization schedule-United States, 2013. Journal of midwifery & women's health. Mar-Apr 2013;58(2):215-220.

CDC. National Early Season Flu Vaccination Coverage. 2012:2-14. http://www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2012.htm. Accessed December.

Bader MS. Immunization for the elderly. Am J Med Sci. Dec 2007;334(6):481-486.

Constenla DO. Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay. Revista panamericana de salud publica = Pan American journal of public health. Aug 2008;24(2):101-112.

Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. The British journal of general practice : the journal of the Royal College of General Practitioners. Oct 2009;59(567):e329-338.

Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama. Jan 8 2003;289(2):179-186.

Colombia MDLPS. Análisis de la situación de salud en Colombia 2002-2007, Morbilidad y Mortalidad. In: Pública UdA-FNdS, ed2007.

CDC. Pneumococcal Disease Epidemiology and Prevention of Vaccine-Preventable Diseases. 12 ed2012:233-248.

Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. The New England journal of medicine. May 1 2003;348(18):1747-1755.

Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. Dec 15 2006;55(RR-17):1-37.

Arango D. Tétanos ¡Todavía un Problema de Salud Pùblica! Iatreia. 7 Feb 2008;21(2):186-198.

Velandia M. Instituto Nacional de Salud. . In: http://www.ins.gov.co/Paginas/inicio.aspx, ed2003.

Population projections of Bogotá and the major demographic indicators 2005 - 2020. Based on data from the 2005 National Population Census. 2005. http://www.dane.gov.co/index.php/poblacion-y-demografia/proyecciones-de-poblacion.

DANE. 2012; http://www.dane.gov.co.

Peláez M, Palloni A, Albala C, Alfonso J, Ham-Chande R, Hennis A. SABE - Encuesta Salud, Bienestar y Envejecimiento. 2004; http://www.ssc.wisc.edu/sabe/docs/informeFinal EspaNol noviembre 2004.pdf.

Colombian-Congress. Estratos y Metodologia. In: Colombia Ro, ed. Law 142, article 1021994.

Sato AP, Antunes JL, Moura RF, de Andrade FB, Duarte YA, Lebrao ML. Factors associated to vaccination against influenza among elderly in a large Brazilian metropolis. PloS one. 2015;10(4):e0123840.

Reyes-Ortiz CA, Davalos DM, Montoya MF, Escobar D. Access to vaccines for Latin American and Caribbean older adults with disability. . In Angel JL, Torres-Gil F, Markides K (Eds); Aging, Health and Longevity in the Mexican-Origin Population. New York: Springer; 2012:159-171

Trejo-Valdivia B, Mendoza-Alvarado LR, Palma-Coca O, Hernández-Ávila M, Téllez-Rojo Solís MM. Encuesta Nacional de Cobertura de Vacunación (influenza, neumococo y tétanos) en adultos mayores de 60 años en México. Salud Pública de México. 2012;54:39-46.

Teitelbaum MA, Edmunds M. Immunization and vaccine-preventable illness, United States, 1992 to 1997. Statistical bulletin. Apr-Jun 1999;80(2):13-20.

Leslie LA, Swider SM. Changing factors and changing needs in women's health care. The Nursing clinics of North America. Mar 1986;21(1):111-123.

Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. Dec 16 2006;333(7581):1241.

Downloads

Download data is not yet available.
Received 2015-09-23
Accepted 2016-01-05
Published 2024-06-07